{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:41:37Z","timestamp":1740170497695,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","award":["G1700929"],"award-info":[{"award-number":["G1700929"]}],"id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40520-021-01892-1","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T09:02:51Z","timestamp":1622019771000},"page":"55-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medications use among women with dementia: a cohort study"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2897-6844","authenticated-orcid":false,"given":"Kailash","family":"Thapaliya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peta M.","family":"Forder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie E.","family":"Byles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"1892_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF03324233","volume":"6","author":"J Thorpe","year":"2013","unstructured":"Thorpe J, Widman L, Wallin A et al (2013) Comorbidity of other chronic age-dependent diseases in dementia. Aging Clin Exp Res 6:159\u2013166. https:\/\/doi.org\/10.1007\/BF03324233","journal-title":"Aging Clin Exp Res"},{"key":"1892_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2165\/00002512-200926060-00006","volume":"26","author":"J Jyrkk\u00e4","year":"2009","unstructured":"Jyrkk\u00e4 J, Enlund H, Korhonen MJ et al (2009) Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons. Drugs Aging 26:493\u2013503. https:\/\/doi.org\/10.2165\/00002512-200926060-00006","journal-title":"Drugs Aging"},{"key":"1892_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/BF03324781","volume":"20","author":"H-M Alanen","year":"2008","unstructured":"Alanen H-M, Finne-Soveri H, Fialova D et al (2008) Use of antipsychotic medications in older home-care patients. Report from nine European countries. Aging Clin Exp Res 20:260\u2013265. https:\/\/doi.org\/10.1007\/BF03324781","journal-title":"Aging Clin Exp Res"},{"key":"1892_CR4","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/pds.1334","volume":"16","author":"G Trifir\u00f2","year":"2007","unstructured":"Trifir\u00f2 G, Verhamme KM, Ziere G et al (2007) All-cause mortality associated with atypical and typical antipsychotics in demented outpatients. Pharmacoepidemiol Drug Saf 16:538\u2013544. https:\/\/doi.org\/10.1002\/pds.1334","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1892_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jamda.2008.02.010","volume":"9","author":"J Cohen-Mansfield","year":"2008","unstructured":"Cohen-Mansfield J, Jensen B (2008) Assessment and treatment approaches for behavioral disturbances associated with dementia in the nursing home: self-reports of physician\u2019s practices. J Am Med Dir Assoc 9:406\u2013413. https:\/\/doi.org\/10.1016\/j.jamda.2008.02.010","journal-title":"J Am Med Dir Assoc"},{"key":"1892_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1371\/journal.pmed.0050076","volume":"5","author":"C Ballard","year":"2008","unstructured":"Ballard C, Lana MM, Theodoulou M et al (2008) A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med 5:587\u2013599. https:\/\/doi.org\/10.1371\/journal.pmed.0050076","journal-title":"PLoS Med"},{"key":"1892_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3233\/JAD-150280","volume":"49","author":"A Jacquin-Piques","year":"2016","unstructured":"Jacquin-Piques A, Sacco G, Tavassoli N et al (2016) Psychotropic drug prescription in patients with Dementia: nursing home residents versus patients living at home. J Alzheimers Dis 49:671\u2013680. https:\/\/doi.org\/10.3233\/JAD-150280","journal-title":"J Alzheimers Dis"},{"key":"1892_CR8","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1017\/S1041610211001438","volume":"23","author":"SU Zuidema","year":"2011","unstructured":"Zuidema SU, de Jonghe JF, Verhey FR et al (2011) Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians\u2019 prescription behavior. Int Psychogeriatr 23:1632\u20131639. https:\/\/doi.org\/10.1017\/S1041610211001438","journal-title":"Int Psychogeriatr"},{"key":"1892_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2165\/00002512-200926060-00005","volume":"26","author":"P Kamble","year":"2009","unstructured":"Kamble P, Chen H, Sherer JT et al (2009) Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs Aging 26:483\u2013492. https:\/\/doi.org\/10.2165\/00002512-200926060-00005","journal-title":"Drugs Aging"},{"key":"1892_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/archinternmed.2009.456","volume":"170","author":"ER Dorsey","year":"2010","unstructured":"Dorsey ER, Rabbani A, Gallagher SA et al (2010) Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med 170:96\u2013103. https:\/\/doi.org\/10.1001\/archinternmed.2009.456","journal-title":"Arch Intern Med"},{"key":"1892_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0004867418758919","volume":"53","author":"J Westbury","year":"2019","unstructured":"Westbury J, Gee P, Ling T et al (2019) More action needed: Psychotropic prescribing in Australian residential aged care. Aust N Z J Psychiatry 53:136\u2013147. https:\/\/doi.org\/10.1177\/0004867418758919","journal-title":"Aust N Z J Psychiatry"},{"key":"1892_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.amjopharm.2009.07.001","volume":"7","author":"PS Nishtala","year":"2009","unstructured":"Nishtala PS, McLachlan AJ, Bell JS et al (2009) Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study. AM J Geriatr Pharmacother 7:210\u2013219. https:\/\/doi.org\/10.1016\/j.amjopharm.2009.07.001","journal-title":"AM J Geriatr Pharmacother"},{"key":"1892_CR13","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"DM Fick","year":"2015","unstructured":"Panel AGSBCUE, Fick DM, Semla TP et al (2015) American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63:2227\u20132246. https:\/\/doi.org\/10.1111\/jgs.13702","journal-title":"J Am Geriatr Soc"},{"key":"1892_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jamda.2019.08.006","volume":"21","author":"AH Dyer","year":"2019","unstructured":"Dyer AH, Murphy C, Lawlor B et al (2019) Cognitive outcomes of Llong-term Benzodiazepine and Related Drug (BDZR) use in people living with mild to moderate Alzheimer\u2019s disease: results from NILVAD. J Am Med Dir Assoc 21:194\u2013200. https:\/\/doi.org\/10.1016\/j.jamda.2019.08.006","journal-title":"J Am Med Dir Assoc"},{"key":"1892_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jamda.2019.02.019","volume":"20","author":"PH van Dam","year":"2019","unstructured":"van Dam PH, Caljouw MA, Sletteb\u00f8 DD et al (2019) Quality of life and pain medication use in persons with advanced dementia living in long-term care facilities. J Am Med Dir Assoc 20:1432\u20131437. https:\/\/doi.org\/10.1016\/j.jamda.2019.02.019","journal-title":"J Am Med Dir Assoc"},{"key":"1892_CR16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.psychres.2015.03.006","volume":"227","author":"B Dt","year":"2015","unstructured":"Dt B, Sofuoglu M, Kerns RD et al (2015) Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration. Psychiatry Res 227:324\u2013332. https:\/\/doi.org\/10.1016\/j.psychres.2015.03.006","journal-title":"Psychiatry Res"},{"key":"1892_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jamda.2017.11.017","volume":"19","author":"EC Tan","year":"2018","unstructured":"Tan EC, Qiu C, Liang Y, Wang R et al (2018) Antihypertensive medication regimen intensity and incident dementia in an older population. J Am Med Dir Assoc 19:577\u2013583. https:\/\/doi.org\/10.1016\/j.jamda.2017.11.017","journal-title":"J Am Med Dir Assoc"},{"key":"1892_CR18","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1517\/13543784.10.10.1847","volume":"10","author":"N Delanty","year":"2001","unstructured":"Delanty N, Vaughan CJ, Sheehy N (2001) Statins and neuroprotection. Expert Opin Investig Drugs 10:1847\u20131853. https:\/\/doi.org\/10.1517\/13543784.10.10.1847","journal-title":"Expert Opin Investig Drugs"},{"key":"1892_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/pds.3381","volume":"22","author":"WB Wong","year":"2013","unstructured":"Wong WB, Lin VW, Boudreau D et al (2013) Statins in the prevention of dementia and Alzheimer\u2019s disease: a meta-analysis of observational studies and an assessment of confounding. Pharmacoepidemiol Drug Saf 22:345\u2013358. https:\/\/doi.org\/10.1002\/pds.3381","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1892_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jgs.14429","volume":"65","author":"U Sarkar","year":"2017","unstructured":"Sarkar U, Lyles C, Steinman M et al (2017) Changes in medication use after dementia diagnosis in an observational cohort of individuals with diabetes mellitus. J Am Geriatr Soc 65:77\u201382. https:\/\/doi.org\/10.1111\/jgs.14429","journal-title":"J Am Geriatr Soc"},{"key":"1892_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s13679-013-0077-4","volume":"3","author":"S Gomersall","year":"2014","unstructured":"Gomersall S, Dobson A, Brown W (2014) Weight gain, overweight, and obesity: determinants and health outcomes from the Australian Longitudinal Study on Women\u2019s Health. Curr Obes Rep 3:46\u201353. https:\/\/doi.org\/10.1007\/s13679-013-0077-4","journal-title":"Curr Obes Rep"},{"key":"1892_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1467-842x.2000.tb00504.x","volume":"24","author":"J Powers","year":"2000","unstructured":"Powers J, Ball J, Adamson L et al (2000) Effectiveness of the National Death Index for establishing the vital status of older women in the Australian Longitudinal Study on Women\u2019s Health. Aust N Z J Public Health 24:526\u2013528. https:\/\/doi.org\/10.1111\/j.1467-842x.2000.tb00504.x","journal-title":"Aust N Z J Public Health"},{"key":"1892_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12982-017-0057-3","volume":"14","author":"M Waller","year":"2017","unstructured":"Waller M, Mishra GD, Dobson AJ (2017) Estimating the prevalence of dementia using multiple linked administrative health records and capture\u2013recapture methodology. Emerg Themes Epidemiol 14:3. https:\/\/doi.org\/10.1186\/s12982-017-0057-3","journal-title":"Emerg Themes Epidemiol"},{"key":"1892_CR24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s13104-015-1616-8","volume":"8","author":"L Mellish","year":"2015","unstructured":"Mellish L, Karanges EA, Litchfield MJ et al (2015) The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers. BMC Res Notes 8:634. https:\/\/doi.org\/10.1186\/s13104-015-1616-8","journal-title":"BMC Res Notes"},{"key":"1892_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/01.mlr.0000108742.26446.17","volume":"42","author":"JD Piette","year":"2004","unstructured":"Piette JD, Wagner TH, Potter MB et al (2004) Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med care 42:102\u2013109. https:\/\/doi.org\/10.1097\/01.mlr.0000108742.26446.17","journal-title":"Med care"},{"key":"1892_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1532-5415.2008.02040.x","volume":"57","author":"SI Haider","year":"2009","unstructured":"Haider SI, Johnell K, Weitoft GR et al (2009) The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc 57:62\u201369. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.02040.x","journal-title":"J Am Geriatr Soc"},{"key":"1892_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1177\/089826439200400404","volume":"4","author":"DL Spore","year":"1992","unstructured":"Spore DL, Horgas AL, Smyer MA et al (1992) The relationship of antipsychotic drug use, behavior, and diagnoses among nursing home residents. J Aging Health 4:514\u2013535. https:\/\/doi.org\/10.1177\/089826439200400404","journal-title":"J Aging Health"},{"key":"1892_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.colegn.2012.02.003","volume":"19","author":"K Ervin","year":"2012","unstructured":"Ervin K, Finlayson S, Cross M (2012) The management of behavioural problems associated with dementia in rural aged care. Collegian 19:85\u201395. https:\/\/doi.org\/10.1016\/j.colegn.2012.02.003","journal-title":"Collegian"},{"key":"1892_CR29","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1017\/S1041610215000654","volume":"27","author":"J Bohlken","year":"2015","unstructured":"Bohlken J, Weber S, Rapp MA et al (2015) Continuous treatment with antidementia drugs in Germany 2003\u20132013: a retrospective database analysis. Int Psychogeriatr 27:1335\u201313342. https:\/\/doi.org\/10.1017\/S1041610215000654","journal-title":"Int Psychogeriatr"},{"key":"1892_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000353859","volume":"60","author":"J Kulmala","year":"2014","unstructured":"Kulmala J, Nyk\u00e4nen I, M\u00e4nty M et al (2014) Association between frailty and dementia: a population-based study. Gerontology 60:16\u201321. https:\/\/doi.org\/10.1159\/000353859","journal-title":"Gerontology"},{"key":"1892_CR31","unstructured":"World Health Organization (2003) World Health Organization fact sheet: obesity and overweight. https:\/\/www.who.int\/dietphysicalactivity\/media\/en\/gsfs_obesity.pdf. Accessed 15 Nov 2019"},{"key":"1892_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1532-5415.2011.03746.x","volume":"601","author":"D Lopez","year":"2012","unstructured":"Lopez D, Flicker L, Dobson A (2012) Validation of the frail scale in a cohort of older Australian women. J Am Geriatr Soc 601:171\u2013173. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03746.x","journal-title":"J Am Geriatr Soc"},{"key":"1892_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jamda.2007.11.005","volume":"92","author":"G Abellan van Kan","year":"2008","unstructured":"Abellan van Kan G, Rolland YM, Morley JE et al (2008) Frailty: toward a clinical definition. J Am Med Dir Assoc 92:71\u201372. https:\/\/doi.org\/10.1016\/j.jamda.2007.11.005","journal-title":"J Am Med Dir Assoc"},{"key":"1892_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/0272431616648452","volume":"371","author":"M Porcu","year":"2017","unstructured":"Porcu M, Giambona F (2017) Introduction to latent class analysis with applications. J Early Adolesc 371:129\u2013158. https:\/\/doi.org\/10.1177\/0272431616648452","journal-title":"J Early Adolesc"},{"key":"1892_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/10705510701575396","volume":"14","author":"KL Nylund","year":"2007","unstructured":"Nylund KL, Asparouhov T, Muth\u00e9n BO (2007) Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Modeling 14:535\u2013569. https:\/\/doi.org\/10.1080\/10705510701575396","journal-title":"Struct Equ Modeling"},{"key":"1892_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.08.029","volume":"88","author":"N Monga","year":"2007","unstructured":"Monga N, Rehm J, Fischer B et al (2007) Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend 88:1\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.08.029","journal-title":"Drug Alcohol Depend"},{"key":"1892_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1111\/biom.12530","volume":"72","author":"A Rouanet","year":"2016","unstructured":"Rouanet A, Joly P, Dartigues J-F et al (2016) Joint latent class model for longitudinal data and interval-censored semi-competing events: application to dementia. Biometrics 72:1123\u20131135. https:\/\/doi.org\/10.1111\/biom.12530","journal-title":"Biometrics"},{"key":"1892_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jpsychores.2012.06.009","volume":"73","author":"ML Harris","year":"2012","unstructured":"Harris ML, Loxton D, Sibbritt DW et al (2012) The relative importance of psychosocial factors in arthritis: findings from 10,509 Australian women. J of Psychosom Res 73:251\u2013256. https:\/\/doi.org\/10.1016\/j.jpsychores.2012.06.009","journal-title":"J of Psychosom Res"},{"key":"1892_CR39","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0031-1301285","volume":"45","author":"M Huber","year":"2012","unstructured":"Huber M, Kolzsch M, Rapp MA et al (2012) Antipsychotic drugs predominate in pharmacotherapy of nursing home residents with dementia. Pharmacopsychiatry 45:182\u2013188. https:\/\/doi.org\/10.1055\/s-0031-1301285","journal-title":"Pharmacopsychiatry"},{"key":"1892_CR40","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/pds.3527","volume":"22","author":"J Schulze","year":"2013","unstructured":"Schulze J, Glaeske G, van den Bussche H et al (2013) Prescribing of antipsychotic drugs in patients with dementia: a comparison with age-matched and sex-matched non-demented controls. Pharmacoepidemiol Drug Saf 22:1308\u20131316. https:\/\/doi.org\/10.1002\/pds.3527","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1892_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/gps.2359","volume":"25","author":"PS Nishtala","year":"2010","unstructured":"Nishtala PS, McLachlan AJ, Bell JS et al (2010) Determinants of antipsychotic medication use among older people living in aged care homes in Australia. Int J Geriatr Psychiatry 25:449\u2013457. https:\/\/doi.org\/10.1002\/gps.2359","journal-title":"Int J Geriatr Psychiatry"},{"key":"1892_CR42","doi-asserted-by":"publisher","first-page":"e0149888","DOI":"10.1371\/journal.pone.0149888","volume":"11","author":"MH De Groot","year":"2016","unstructured":"De Groot MH, Van Campen JP, Kosse NM et al (2016) The association of medication-use and frailty-related factors with gait performance in older patients. PLoS ONE 11:e0149888. https:\/\/doi.org\/10.1371\/journal.pone.0149888","journal-title":"PLoS ONE"},{"key":"1892_CR43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/JGP.0b013e318167ae76","volume":"16","author":"G Selb\u00e6k","year":"2008","unstructured":"Selb\u00e6k G, Kirkevold \u00d8, Engedal K (2008) The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes\u2014a 12-month follow-up study. Am J Geriatr Psychiatry 16:528\u2013536. https:\/\/doi.org\/10.1097\/JGP.0b013e318167ae76","journal-title":"Am J Geriatr Psychiatry"},{"key":"1892_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/gps.5105","volume":"34","author":"KE Lind","year":"2019","unstructured":"Lind KE, Gray LC, Raban MZ et al (2019) Antidementia medication use by aged care facility residents with dementia. Int J Geriatr Psychiatry 34:1029\u20131040. https:\/\/doi.org\/10.1002\/gps.5105","journal-title":"Int J Geriatr Psychiatry"},{"key":"1892_CR45","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1001\/jama.2010.1482","volume":"304","author":"MA Steinman","year":"2010","unstructured":"Steinman MA, Hanlon JT (2010) Managing medications in clinically complex elders:\u201cthere\u2019s got to be a happy medium.\u201d JAMA 304:1592\u20131601. https:\/\/doi.org\/10.1001\/jama.2010.1482","journal-title":"JAMA"},{"key":"1892_CR46","unstructured":"Therapeutic Good Administration (2015) Risperidone and risk of cerebrovascular adverse events in dementia patients. https:\/\/www.tga.gov.au\/publication-issue\/medicines-safety-update-volume-6-number-4-august-2015. Accessed 13 Nov 2019"},{"key":"1892_CR47","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/jgs.14226","volume":"64","author":"D Koller","year":"2016","unstructured":"Koller D, Hua T, Bynum JP (2016) Treatment patterns with antidementia drugs in the United States: medicare cohort study. J Am Geriatr Soc 64:1540\u20131548. https:\/\/doi.org\/10.1111\/jgs.14226","journal-title":"J Am Geriatr Soc"},{"key":"1892_CR48","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7326\/0003-4819-148-5-200803040-00009","volume":"148","author":"P Raina","year":"2008","unstructured":"Raina P, Santaguida P, Ismaila A et al (2008) Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 148:379\u2013397. https:\/\/doi.org\/10.7326\/0003-4819-148-5-200803040-00009","journal-title":"Ann Intern Med"},{"key":"1892_CR49","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1503\/cmaj.070804","volume":"179","author":"N Herrmann","year":"2008","unstructured":"Herrmann N, Gauthier SJC (2008) Diagnosis and treatment of dementia: 6 Management of severe Alzheimer disease. CMAJ 179:1279\u20131287. https:\/\/doi.org\/10.1503\/cmaj.070804","journal-title":"CMAJ"},{"key":"1892_CR50","unstructured":"Demenetia Australia (2019) Medication use by people living with dementia. https:\/\/www.dementia.org.au\/sites\/default\/files\/media\/Medication%20use%20by%20people%20living%20with%20dementia.pdf. Accessed 23 Apr 2021"},{"key":"1892_CR51","unstructured":"Dementia Australia (2011) Dementia across Australia: 2011\u20132050. https:\/\/www.dementia.org.au\/sites\/default\/files\/20111014_Nat_Access_DemAcrossAust.pdf. Accessed 8 Nov 2019"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-021-01892-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-021-01892-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-021-01892-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T10:23:46Z","timestamp":1643279026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-021-01892-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1892"],"URL":"https:\/\/doi.org\/10.1007\/s40520-021-01892-1","relation":{},"ISSN":["1720-8319"],"issn-type":[{"type":"electronic","value":"1720-8319"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"21 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial or personal conflicts of interest with the work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ALSWH project has ongoing ethical clearance from both the University of Newcastle and the University of Queensland\u2019s Human Research Ethics Committees. Data linkage was approved by the Australian Institute of Health and Welfare (AIHW), Australia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participant"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}